Amoxapine and amitriptyline: serum levels and clinical response in patients with primary unipolar depression
- PMID: 6749828
Amoxapine and amitriptyline: serum levels and clinical response in patients with primary unipolar depression
Abstract
Amoxapine, a new antidepressant of the dibenzoxazepine class, was compared with amitriptyline in 80 patients with primary unipolar depressive disorders. In a four-week double-blind trial, the two medications were equally effective and had similar onsets of therapeutic action. The range of side effects was similar, although there was a trend for fewer side effects in the amoxapine group. Serum levels were not related to therapeutic response for either medication.